Work

34820 Real-world treat-to-target skin clearance with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry

Year: 2022

Type: article

Study design: Observational Study

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2022.06.833

Authors: April W. Armstrong, Laura K. Ferris, Kristina Callis Duffin, Jud Janak, Adam Sima, Thomas Eckmann, Manish Patel, Huzefa Photowala, Vishvas Garg, Bruce Strober

Institutions: University of Southern California, University of Pittsburgh Medical Center, University of Utah, AbbVie (United States), Yale University

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295255684

FWCI: 0.077

Cites:

Cited by: 1

Related to: 10